Barclays’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$819 Buy
+72
New +$1.38K ﹤0.01% 4950
2022
Q3
Hold
0
-$8K 4917
2022
Q2
Hold
0
4688
2022
Q1
Hold
0
4550
2021
Q4
Hold
0
4012
2021
Q3
Hold
0
4313
2021
Q2
Sell
-1
Closed -$164K 4228
2021
Q1
$109K Buy
+1
New +$220K ﹤0.01% 3965
2020
Q4
Hold
0
4512
2020
Q3
Sell
-2
Closed -$315K 4571
2020
Q2
$247K Buy
+2
New +$245K ﹤0.01% 3901
2020
Q1
Hold
0
6251
2019
Q4
Hold
0
6514

Other funds holding GNPX

Barclays's GNPX Position: Q2 2026 in Review

Barclays opened a new position in Genprex (GNPX) in Q2 2026: 72 shares worth $819. The stake represents ﹤0.01% of the portfolio and ranks #4950 among its holdings. This is a return to the name: Barclays previously reported a position in GNPX as recently as Q1 2021.

Barclays first reported a position in GNPX in Q2 2020 and has held it in 3 quarters since. The position peaked at $247K in Q2 2020. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Barclays held 72 shares of Genprex worth $819 as of Q2 2026.
  • Genprex was a new Barclays position in Q2 2026.
  • Genprex made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4950 holding.
  • Barclays first reported a position in Genprex in Q2 2020 and has held it in 3 quarters since.
  • Barclays's Genprex position peaked at $247K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.